Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex

被引:209
作者
Gewin, L
Myers, H
Kiyono, T
Galloway, DA [1 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA
[2] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98125 USA
关键词
telomerase; HPV; transcriptional repressor; ubiquitin; E6; E6-AP;
D O I
10.1101/gad.1214704
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
The critical immortalizing activity of the human papillomavirus (HPV) type-16 E6 oncoprotein is to induce expression of hTERT, the catalytic and rate-limiting subunit of telomerase. Additionally, E6 binds to a cellular protein called E6-associated protein (E6-AP) to form an E3 ubiquitin ligase that targets p53 for proteasome-dependent degradation. Although telomerase induction and p53 degradation are separable and distinct functions of E6, binding of E6 to E6-AP strongly correlated with the induction of hTERT. Here, we demonstrate using shRNAs to reduce E6-AP expression that E6-AP is required for E6-mediated telomerase induction. A yeast two-hybrid screen to find new targets of the E6/E6-AP E3 ubiquitin ligase complex identified NFX1. Two isoforms of NFX1 were found: NFX1-123, which coactivated with c-Myc at the hTERT promoter, and NFX1-91, which repressed the hTERT promoter. NFX1-91 was highly ubiquitinated and destabilized in epithelial cells expressing E6. Furthermore, knockdown of NFX1-91 by shRNA resulted in derepression of the endogenous hTERT promoter and elevated levels of telomerase activity. We propose that the induction of telomerase by the HPV-16 E6/E6-AP complex involves targeting of NFX1-91, a newly identified repressor of telomerase, for ubiquitination and degradation.
引用
收藏
页码:2269 / 2282
页数:14
相关论文
共 60 条
[1]
Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity [J].
Baege, AC ;
Berger, A ;
Schlegel, R ;
Veldman, T ;
Schlegel, R .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (04) :1251-1257
[2]
Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein [J].
Bartz, SR ;
Vodicka, MA .
METHODS-A COMPANION TO METHODS IN ENZYMOLOGY, 1997, 12 (04) :337-342
[3]
Boyer SN, 1996, CANCER RES, V56, P4620
[4]
Single-column purification of free recombinant proteins using a self-cleavable affinity tag derived from a protein splicing element [J].
Chong, SR ;
Mersha, FB ;
Comb, DG ;
Scott, ME ;
Landry, D ;
Vence, LM ;
Perler, FB ;
Benner, J ;
Kucera, RB ;
Hirvonen, CA ;
Pelletier, JJ ;
Paulus, H ;
Xu, MQ .
GENE, 1997, 192 (02) :271-281
[5]
Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells [J].
Cong, YS ;
Bacchetti, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (46) :35665-35668
[6]
Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells [J].
Dalal, S ;
Gao, QS ;
Androphy, EJ ;
Band, V .
JOURNAL OF VIROLOGY, 1996, 70 (02) :683-688
[7]
Dessain SK, 2000, CANCER RES, V60, P537
[8]
Devereux TR, 1999, CANCER RES, V59, P6087
[9]
A DNA damage checkpoint response in telomere-initiated senescence [J].
di Fagagna, FD ;
Reaper, PM ;
Clay-Farrace, L ;
Fiegler, H ;
Carr, P ;
von Zglinicki, T ;
Saretzki, G ;
Carter, NP ;
Jackson, SP .
NATURE, 2003, 426 (6963) :194-198
[10]
A BIOMARKER THAT IDENTIFIES SENESCENT HUMAN-CELLS IN CULTURE AND IN AGING SKIN IN-VIVO [J].
DIMRI, GP ;
LEE, XH ;
BASILE, G ;
ACOSTA, M ;
SCOTT, C ;
ROSKELLEY, C ;
MEDRANO, EE ;
LINSKENS, M ;
RUBELJ, I ;
PEREIRASMITH, O ;
PEACOCKE, M ;
CAMPISI, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9363-9367